$11.37
0.020.18%
Last update: Nov 10, 5:51 PM
Corvus Pharmaceuticals Inc
CRVSNASDAQ
Corvus Pharmaceuticals rose 43.5% from $7.91 to $11.35, ahead of the S&P 500's +10.0%. Its worst day was May 14 (−13.8%), and its low came Jan 13 at $6.50.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Corvus Pharmaceuticals closed at its lowest level of the year, 17.8% below where the year started.
−3.7% · S&P 500 −0.2%
Corvus Pharmaceuticals closed at its highest level of the year, 222.6% above where the year started.
Story events cover the past 12 months · Times ET
+15.2% · S&P 500 +0.5%
EPS of $-0.15 missed the $-0.14 estimate on $0.00 revenue (est. $620,000.00).
−4.3% · S&P 500 −0.6%
EPS of $-0.15 beat the $-0.15 estimate on $0.00 revenue (est. $620,000.00).
+6.6% · S&P 500 +0.8%
EPS of $-0.19 missed the $-0.17 estimate on $0.00 revenue.
+0.4% · S&P 500 +0.6%
EPS of $-0.22 missed the $-0.21 estimate on $0.00 revenue.
+8.3% · S&P 500 +0.3%
Where it ended: a close of $11.35 on Nov 9, 2026.
Nothing in the past 12 months.
All CRVS dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for CRVS and SPY from Benzinga historical bars. Not investment advice.
